A surprise discovery that overturns decades of thinking about how the body fixes proteins that come unraveled greatly expands opportunities for therapies to prevent diseases such as Alzheimer’s and Parkinson’s, which have been linked to the accumulation of improperly folded proteins in the brain.
Researchers at UC San Francisco and UC Berkeley have teamed up to create an innovative, integrated center for research on neurodegenerative diseases. Supported by a $3 million grant from the Glenn Foundation for Medical Research, the new center aims to pave the way to developing novel treatments for diseases such as Alzheimer’s disease and Parkinson’s disease.
The National Institutes of Health today announced its first research grants through President Barack Obama’s BRAIN Initiative, including three awards to the University of California, Berkeley, totaling nearly $7.2 million over three years.
Two state-of-the-art research areas – nanotech and optogenetics – were the dominant theme last Thursday, Sept. 18, as six researchers from UC Berkeley, UC San Francisco and Lawrence Berkeley National Laboratory sketched out their teams’ bold plans to jump-start new brain research.
UC Berkeley researchers have found that the human brain is capable of a neural workaround that compensates for the buildup of beta-amyloid, a destructive protein associated with Alzheimer’s disease. The findings could help explain how some older adults with beta-amyloid deposits in their brain retain normal cognitive function while others develop dementia.
Are humans programmed to tell the truth? Not when lying is advantageous, says a new study led by Assistant Professor Ming Hsu at UC Berkeley’s Haas School of Business. The report ties honesty to a region of the brain that exerts control over automatic impulses.
A year-long project will focus on standardizing a subset of neuroscience data, making this research simpler for scientists to share. This is the first collaboration launched by “Neurodata Without Borders,” a broader initiative with the goal of standardizing neuroscience data on an international scale, making it more easily sharable by researchers worldwide.
People playing betting games engage two main areas of the brain: the medial prefrontal cortex and the striatum. Ming Hsu of UC Berkeley and Eric Set of the University of Illinois scanned 12 genes involved in dopamine regulation in these areas and found that people’s genetic variants affected how they dealt with trial-and-error learning and belief learning.
Neuroscientists, engineers and physicians are teaming up for an ambitious five-year, $26 million project to develop new techniques for tackling mental illness.
UC Berkeley neuroscientist Daniela Kaufer and colleagues in Israel and Germany have shown in rats that a drug commonly prescribed for hypertension can nearly eliminate the epilepsy that often follows severe head injury. Nearly one in five cases of epilepsy is the result of head trauma.
When Hollywood knocked on the doors of UC Berkeley engineering professors Michel Maharbiz and Jose Carmena, the researchers answered. Director Wally Pfister tapped their expertise in neural engineering and brain-machine interfaces during the filming of his movie, “Transcendence,” which opens in theaters April 18.
Ehud Isacoff and his colleagues explore the brain at several levels critical to ultimately understand how memories form and what can threaten their demise. He is the Director of Berkeley’s Helen Wills Neuroscience Institute.
